Tommorrows medicines, today

Genus: part of the STADA group

Genus is owned by Frankfurt based STADA Arzneimittel AG

STADA is a pan european pharmaceutical company that develops, manufactures, markets and distributes branded and generic pharmaceutical products. With sales of well over one billion Euros, STADA affords Genus with both research and development support and financial investment.

An essential factor for the continued success of STADA’s business model is its individual market focus through the international network of local marketing and sales companies such as Genus Pharmaceuticals in the UK. In order to rapidly adapt to individual country healthcare market changes, STADA’s local sales companies retain a high level of autonomy, allowing the flexibility to adapt and capitalise on local country market opportunities.

Coming together is a beginning; keeping together is progress; working together is success

- Henry Ford